Insider holders · CIK 0001383701
Conatus Pharmaceuticals Inc. · CNAT
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Steven J MentoPresident, CEO & Director | 60,000 | 427,083 | 487,083 | May 7, 2018 · 7:46 pm EDT | Form 4 |
| Alfred P. SpadaEVP, R&D and CSO | 12,121 | 247,142 | 259,263 | Mar 1, 2018 · 4:08 pm EST | Form 4 |
| Charles CashionSVP, Finance, CFO and Sec. | 42,424 | 144,738 | 187,162 | Jan 11, 2017 · 4:01 pm EST | Form 4 |
| Daniel L. RipleySVP, Bus Dev, P&A Mgmt | — | 32,431 | 32,431 | Feb 11, 2019 · 4:19 pm EST | Form 4 |
| Harold Van WartDirector | 18,181 | — | 18,181 | Oct 31, 2016 · 4:37 pm EDT | Form 4 |
| Edward F Smith IIISVP, Reg Affairs and QA | 10,875 | — | 10,875 | Feb 11, 2019 · 4:20 pm EST | Form 4 |
| Daniel L KisnerDirector | 4,000 | 5,455 | 9,455 | Dec 30, 2016 · 5:24 pm EST | Form 4 |
| Michelle L VandertieVice President, Finance | — | 2,813 | 2,813 | Feb 5, 2018 · 5:05 pm EST | Form 5 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.